SYNAGEVA BIOPHARMA CORP - COM (GEVA)

CUSIP: 87159A103

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
30,623,264
Share change
-26,814
Total reported value
$1,982,085,073
Put/Call ratio
32%
Price per share
$64.72
Number of holders
81
Value change
-$1,726,833
Number of buys
1
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 87159A103?
CUSIP 87159A103 identifies GEVA - SYNAGEVA BIOPHARMA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNAGEVA BIOPHARMA CORP - COM (GEVA) as of Q4 2013

As of 31 Dec 2013, SYNAGEVA BIOPHARMA CORP - COM (GEVA) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,623,264 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Capital Research Global Investors, COLUMBIA WANGER ASSET MANAGEMENT LLC, FMR LLC, JANUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BB Biotech AG, BlackRock Fund Advisors, Sectoral Asset Management Inc, and BlackRock Institutional Trust Company, N.A.. This page lists 81 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.